In vitro hemocompatibility testing of medical devices
- PMID: 32698094
- DOI: 10.1016/j.thromres.2020.07.027
In vitro hemocompatibility testing of medical devices
Abstract
Hemocompatibility testing is essential for the safe use of medical devices that come into contact with blood. There are various evaluation methodologies. In vivo, ex vivo and in vitro systems can be used and different categories can be evaluated in different ways. This review deals with in vitro hemocompatibility testing mainly on the basis of ISO standard 10993-4 recommendations and possibly new research results. This is a summary of all tested categories, i.e. coagulation, hemolysis, hematology and activation of leukocytes and platelets and the complement system. The main principle of evaluation and the possibilities of testing using various methodologies are always described. In the next part, variants of the method of blood incubation with the tested medical device from the static system to the circulation are described. Circulation can be provided, for example, by means of the Chandler Loop or parallel-plate chambers.
Keywords: Coagulation; Hemocompatibility; Human blood; Leukocyte; Platelet.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Similar articles
-
[Considerations on in vitro and in vivo magnetic nanoparticles hemocompatibility testing].Rev Med Chir Soc Med Nat Iasi. 2009 Jan-Mar;113(1):279-85. Rev Med Chir Soc Med Nat Iasi. 2009. PMID: 21495331 Romanian.
-
Hemocompatibility studies on a degradable polar hydrophobic ionic polyurethane (D-PHI).Acta Biomater. 2017 Jan 15;48:368-377. doi: 10.1016/j.actbio.2016.11.005. Epub 2016 Nov 3. Acta Biomater. 2017. PMID: 27818307
-
Hemocompatibility testing according to ISO 10993-4: discrimination between pyrogen- and device-induced hemostatic activation.Mater Sci Eng C Mater Biol Appl. 2014 Sep;42:422-8. doi: 10.1016/j.msec.2014.05.070. Epub 2014 Jun 6. Mater Sci Eng C Mater Biol Appl. 2014. PMID: 25063137
-
Hemocompatibility of inhaled environmental nanoparticles: Potential use of in vitro testing.J Hazard Mater. 2017 Aug 15;336:158-167. doi: 10.1016/j.jhazmat.2017.04.041. Epub 2017 Apr 27. J Hazard Mater. 2017. PMID: 28494303 Review.
-
Blood-Contacting Biomaterials: In Vitro Evaluation of the Hemocompatibility.Front Bioeng Biotechnol. 2018 Jul 16;6:99. doi: 10.3389/fbioe.2018.00099. eCollection 2018. Front Bioeng Biotechnol. 2018. PMID: 30062094 Free PMC article. Review.
Cited by
-
Erythrocyte Vulnerability to Airborne Nanopollutants.Toxics. 2024 Jan 21;12(1):92. doi: 10.3390/toxics12010092. Toxics. 2024. PMID: 38276727 Free PMC article.
-
Modification of titanium orthopedic implants with bioactive glass: a systematic review of in vivo and in vitro studies.Front Bioeng Biotechnol. 2023 Nov 15;11:1269223. doi: 10.3389/fbioe.2023.1269223. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 38033819 Free PMC article.
-
Amygdalin/chitosan-polyvinyl alcohol/cerium-tannic acid hydrogel as biodegradable long-time implant for cancer recurrence care applications: An in vitro study.Heliyon. 2023 Nov 5;9(11):e21835. doi: 10.1016/j.heliyon.2023.e21835. eCollection 2023 Nov. Heliyon. 2023. PMID: 38027646 Free PMC article.
-
Hemocompatibility of β-Cyclodextrin-Modified (Methacryloyloxy)ethyl Phosphorylcholine Coated Magnetic Nanoparticles.Biomolecules. 2023 Jul 25;13(8):1165. doi: 10.3390/biom13081165. Biomolecules. 2023. PMID: 37627230 Free PMC article.
-
Preclinical in vitro evaluation of implantable materials: conventional approaches, new models and future directions.Front Bioeng Biotechnol. 2023 Jul 27;11:1193204. doi: 10.3389/fbioe.2023.1193204. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37576997 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
